A Yin-Yang role for metals in prion disease

Panminerva Medica

Volumn 43, Issue 4, 2001, Pages 283-287

  Wong, B S ^b   Brown, D R ^a   Sy, M S ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Copper; Metals; Oxidative stress; Prion diseases; Prions; Superoxide dismutase

Indexed keywords

COPPER; METAL;

ANIMAL; BRAIN; HUMAN; METABOLISM; PRION; PRION DISEASE; PROTEIN BINDING; REVIEW;

ANIMALS; BRAIN; COPPER; HUMANS; METALS; PRION DISEASES; PRIONS; PROTEIN BINDING;

EID: 0035656122     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Caughey B. Transmissible spongiform encephalopathies, amyloidoses and yeast prions: common threads? Nat Med 2000;6:751-4.
2. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998;95:13363-83.
3. Keyes ME. The prion challenge to the "central dogma" of molecular biology, 1965-1991, Part II: The problem with prions. Stud Hist Phil Biol Biomed Sci 1999;30:181-218.
4. Alper T, Cramp WA, Haig DA, Clarke MC. Does the agent of scrapie replicate without nucleic acid? Nature 1967;214:764-6.
5. Alper T, Haig DA, Clarke MC. The exceptionally small size of the scrapie agent. Biochem Biophys Res Commun 1966;22:278-84.
6. Griffith JS. Self-replication and scrapie. Nature 1967;215:1043-4.
7. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982;216:136-44.
8. Brown DR. Prion and prejudice: normal protein and the synapse. Trends Neurosci 2001;24:85-90.
9. Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R et al. The cellular prion protein binds copper in vivo. Nature 1997;390: 684-7.
10. Brown DR, Schulz-Schaeffer WJ, Schmidt B, Kretzschmar HA. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp Neurol 1997;146:104-12.
11. White AR, Collins SJ, Maher F, Jobling MF, Stewart RL, Thyer JM et al. Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity. Am J Pathol 1999;155:1723-30.
12. Wong BS, Liu T, Li RL, Pan T, Petersen RB, Smith MA et al. Increased levels of oxidative stress markers detected in the brains of prion knockout mice. J Neurochem 2001;76:565-72.
13. Bush AI. Metals and neuroscience. Curr Opin Chem Biol 2000;4: 184-91.
14. Donne DG, Viles JH, Groth D, Mehlhorn I, James TL, Cohen FE et al. Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc Natl Acad Sci U S A 1997;94:13452-7.
15. Lopez Garcia F, Zahn R, Riek R, Wuthrich K. NMR structure of the bovine prion protein. Proc Natl Acad Sci U S A 2000;97:8334-9.
16. Riek R, Hornemann S, Wider G, Glockshuber R, Wuthrich K. NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett 1997;413:282-8.
17. Zahn R, Liu A, Luhrs T, Riek R, von Schroetter C, Lopez Garcia F et al. NMR solution structure of the human prion protein. Proc Natl Acad Sci U S A 2000;97:145-50.
18. Schatzl HM, Da Costa M, Taylor L, Cohen FE, Prusiner SB. Prion protein gene variation among primates. J Mol Biol 1995;245:362-74.
19. Wopfner F, Weidenhufer G, Schneider R, von Brum A, Glich S, Schwartz TF et al. Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein. J Mol Biol 1999;289:1163-78.
20. Brown DR, Haliz F, Glasssmith LL, Wong BS, Jones IM, Clive C et al. Consequences of manganese replacement of copper for prion protein function and proteinase resistance. EMBO J 2000;19:1180-6.
21. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2001;24:519-50.
22. Hornshaw MP, McDermott JR, Candy JM, Lakey JH, Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein: structural studies using synthetic peptides. Biochem Biophys Res Commun 1995;214:993-9.
23. Brown DR. Prion protein expression aids cellular uptake and veratridine-induced release of copper. J Neurosci Res 1999;58:717-25.
24. Miura T, Hori-i A, Mototani H, Takeuchi H. Raman spectroscopic study on the copper(II) binding mode of prion octapeptide and its pH dependence. Biochemistry 1999;38:11560-9.
25. Qin K, Yang DS, Yang Y, Chshti MA, Meng LJ, Kretzschmar MA et al. Copper(II)-induced conformational changes and protease resistance in recombinant and cellular PrP. Effect of protein age and deamidastion. J Biol Chem 2000;275:19121-31.
26. Wong BS, Venien-Bryan C, Williamson RA, Burton DR, Gambetti P, Sy MS et al. Copper refolding of prion protein. Biochem Biophys Res Commun 2000;276:1217-24.
27. Quaglio E, Chiesa R, Harris DA. Copper converts the cellular prion protein into a protease resistant species that is distinct from the serapie isoform. J Biol Chem 2001;276:11432-8.
28. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992;356:577-82.
29. Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I, Hope J. 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 1994;8:121-7.
30. Colling SB, Collinge J, Jefferys JG. Hippocampal slices from prion protein null mice: disrupted Ca(2+)- activated K+ currents. Neurosci Lett 1996;209:49-52.
31. Lledo PM, Tremblay P, DeArmond SJ, Prusiner SB, Nicoll RA. Mice deficient for prion protein exhibit normal neuronal excitability and synaptic transmission in the hippocampus. Proc Natl Acad Sci USA 1996;93:2403-7.
32. Brown DR, Schmidt B, Kretzschmar HA. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature 1996;380:345-7.
33. Brown DR, Besinger A. Prion protein expression and superoxide dismutase activity. Biochem J 1998;334:423-9.
34. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 3rd edition. New York: Oxford University Press, 1999.
35. Brown DR, Wong BS, Hafiz F, Clive C, Haswell S, Jones IM. Normal prion protein has an activity like thai of superoxide dismutase. Biochem J 1999;344:1-5.
36. Brown DR, Clive C, Haswell SJ. Anti-oxidant activity related to copper binding of native prion protein. J Neurochem 2001;76:69-76.
37. Wong BS, Wang H, Brown DR, Jones IM. Selective oxidation of methionine residues in prion proteins. Biochem Biophys Res Commun 1999;259:352-5.
38. Pauly PC, Harris DA. Copper stimulates endocytosis of the prion protein. J Biol Chem 1998;273:33107-10.
39. Shils ME, Olson JA, Shike M, Ross AC. Modern nutrition in health and disease. 9th edition. Baltimore: Lippincott Williams & Wilkins, 1999.
40. Sayre LM, Perry G, Smith MA. Redox metals and neurodegenerative disease. Curr Opin Chem Biol 1999;3:220-5.
41. Deibel MA, Ehmann WD, Markesbery WR. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J Neurol Sci 1996;143:137-42.
42. Pattison IH, Jebbett JN. Histopathological similarities between serapie and cuprizone toxicity in mice. Nature 1971;230:115-7.
43. Kimberlin RH, Millson GC, Bountiff L, Collis SC. A comparison of the biochemical changes induced in mouse brain cuprizone toxicity and by scrapie infection. J Comp Pathol 1974;84:263-70.
44. Kim N, Park S, Jin JK, Kwon MS, Choi EK, Carp RI et al. Increased ferric iron content and iron-induced oxidative stress in the brains of scrapie-infected mice. Brain Res 2000;884:98-103.
45. Brown P, Rau EH, Johnson BK, Bacote AE, Gibbs CJ Jr, Gajdusek DC. New studies on the heat resistance of hamster-adapted scrapie agent: threshold survival after ashing at 600°C suggests an inorganic template of replication. Proc Natl Acad Sci USA 2000;97: 3418-21.
46. Purdey M. Ecosystems supporting clusters of sporadic TSEs demonstrate excesses of the radical-generating divalent cation manganese and deficiencies of antioxidant co factors Cu, Se, Fe, Zn. Med Hypotheses 2000;54:278-306.
47. Milhavet O, McMahon HE, Rachidi W, Nishida N, Katamine S, Mange A et al. Priori infection impairs the cellular response to oxidative stress. Proc Natl Acad Sci USA 2000;97:13937-42.
48. Guentchev M, Voigtlander T, Haberler C, Groschup MH, Budka H. Evidence for oxidative stress in experimental prion disease. Neurobiol Dis 2000;7:270-3.
49. Scott MR, Groth D, Tatzelt J, Torchia M, Tremblay P, De Armond SJ et al. Propagation of prion strains through specific conformers of the prion protein. J Virol 1997;71:9032-44.
50. Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M et al. Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 1998;4:1157-65.
51. Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R et al. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 1996;274:2079-82.
52. Carp RI, Merz PA, Kascsak RJ, Merz GS, Wisniewski HM. Nature of the scrapie agent: current status of facts and hypotheses. J Gen Virol 1985;66:1357-68.
53. Wadsworth JDF, Hill AF, Joiner S, Jackson GS, Clarke AR, Collinge J. Strain-specific prion-protein conformation determined by metal jons. Nat Cell Biol 1999;1:55-9.
54. McKenzie D, Bartz J, Mirwald J, Olander D, Marsh R, Aiken J. Reversibility of scrapie inactivation is enhanced by copper. J Biol Chem 1998;273:25545-7.